Kurse werden geladen...
Prognose
Für dieses Unternehmen liegen uns keine Analysten-Daten vor.
Scoring-Modelle
Dividenden-Strategie | 10 / 15 |
HGI-Strategie | 3 / 18 |
Levermann-Strategie | -1 / 13 |
News
Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices
BOULDER, CO / ACCESSWIRE / December 5, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, today announced it has successfully completed transition to the new European Union (EU) Medical Device Regulation (MDR) for four of its products in Europe. Sonoma was granted classification as a Class IIb medical device for Microdacyn60® Wound Care and Microdacyn60 Hydrogel, its scar gel product Epicyn®, and Pediacyn® for atopic dermatitis.» Mehr auf accesswire.com
Despite Fast-paced Momentum, Sonoma Pharmaceuticals (SNOA) Is Still a Bargain Stock
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Sonoma Pharmaceuticals (SNOA) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.» Mehr auf zacks.com
Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States
BOULDER, CO / ACCESSWIRE / November 21, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, today announced the relaunch of its prescription dermatology and eye care products lines. The prescription-strength products include: Acuicyn® Eyelid & Eyelash Hygiene, Epicyn® Facial Cleanser, Levicyn® Dermal Spray, Levicyn® Gel, Levicyn® Spray Gel and Celacyn® Scar Management Gel.» Mehr auf accesswire.com
Historische Dividenden
Alle Dividenden KennzahlenUnternehmenszahlen
(EUR) | Sep. 2024 | |
---|---|---|
Umsatz | 3,21 Mio | 24,58% |
Bruttoeinkommen | 1,22 Mio | 30,69% |
Nettoeinkommen | −547,76k | 60,92% |
EBITDA | −731,84k | 33,38% |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 3,44 Mio€ |
Anzahl Aktien | 1,34 Mio |
52 Wochen-Hoch/Tief | 9,11€ - 2,37€ |
Dividendenrendite | 8,13% |
Dividenden TTM | 0,19€ |
Beta | 1,38 |
KGV (PE Ratio) | −0,74 |
KGWV (PEG Ratio) | −0,01 |
KBV (PB Ratio) | 0,51 |
KUV (PS Ratio) | 0,26 |
Unternehmensprofil
American Shipping Company ASA ist über ihre Tochtergesellschaften als Schiffseigner und Leasingfinanzierer in den Vereinigten Staaten tätig. Das Unternehmen erwirbt und verchartert Produktentanker, Shuttle-Tanker und andere Schiffe an Betreiber und Endverbraucher auf dem Jones Act-Markt. Es betreibt eine Flotte von neun Produktentankern und einem Shuttle-Tanker. Das Unternehmen war früher als Aker American Shipping ASA bekannt und änderte im Juni 2008 seinen Namen in American Shipping Company ASA. American Shipping Company ASA wurde im Jahr 2005 gegründet und hat seinen Hauptsitz in Lysaker, Norwegen.
Name | American Shipping |
CEO | Amy M. Trombly |
Sitz | Woodstock, ga Norwegen |
Website | |
Industrie | Seetransport |
Börsengang | 17.04.2009 |
Mitarbeiter | 10 |
Ticker Symbole
Börse | Symbol |
---|---|
Ose | AMSC.OL |
Frankfurt | X5A.F |
London | 0JE5.L |
München | X5A.MU |
Stockholm | AMSC.ST |
Osl | AMSC.OL |
Euronext | AMSC.OL |
London Stock Exchange | 0JE5.L |
Pnk | ASCJF |
NASDAQ | SNOA |
Nasdaq Copenhagen | HUSCO.CO |
Nse | ADORWELD.NS |
Shz | 002681.SZ |
Koe | 214450.KQ |
Japan Exchange Group | 7915.T |
Australian Securities Exchange Ltd | PUA.AX |
Bse | GENPHARMA.BO |
Sto | PRFO.ST |
Ksc | 102780.KS |
XETRA | UIMC.DE |
Jnb | STXWDM.JO |
Düsseldorf | X5A.DU |
Assets entdecken
Shareholder von American Shipping investieren auch in folgende Assets